In turn, this study demonstrated that LDHA, a cancer stemness promoter, could impede the infiltration of anti-tumor immune cells (CD4+/CD8+ T cells) and enhance the accumulation of the pro-tumoral immune cells (MDSCs and TAMs) in TME. The gene discussed is CD8A; the disease is neoplasm.